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The properties of connective tissues vary with biological demand: Thus, the extracellular 
matrix (ECM) in the skin has to bear tensile forces, while the ECM in cartilage needs to resist 
compression forces and mechanical pressure. These characteristic properties are conferred 
by the specific biochemical composition of the matrices, which in turn determine their 
structural properties. 
COMP is a characteristic and abundant component of cartilage ECM in which it interacts with 
the collagen network. By virtue of its pentameric structure COMP is capable of binding with 
up to 5 collagen molecules, thereby controlling collagen fibril formation, which strongly 
depends upon the molar ratio between collagen and COMP. 
In healthy skin, COMP is detected in subepidermal regions below the basement membrane 
and transiently in close proximity to hair follicles. Fibrotic alterations in the dermal ECM are 
characterized by structural changes of the collagenous matrix which coincide with skin 
stiffening. These processes are accompanied by changes in the molecular composition of 
the ECM, and large amounts of COMP are deposited into the fibrotic matrix. 
The aim of this dissertation was to characterize which processes contribute to the deposition 
of COMP into dermal ECM, and whether these are responsible for the structural alterations 
of fibrotic ECM. These questions were addressed by employing genetically modified mouse 
models. 
Deposition of COMP into the dermal ECM was detected not only in fibrotically altered dermis 
but also in healthy skin during hair follicle morphogenesis. In both situations enhanced 
COMP deposition was induced by mechanical forces within the skin, potentially attempting to 
maintain the integrity of the collagen matrix. In line with this concept, the collagen matrix of 
COMP-deficient mice was altered with severely reduced spacing between fibrils and with 
altered fibril morphology. Dermal fibroblasts derived from COMP-deficient mice exhibited ER 
stress and disturbed protein secretion, which might explain the reduced production of ECM 
components by these mice upon induction of experimental skin fibrosis. 
A mouse line was generated with constitutive, fibroblast-restricted overexpression of COMP. 
This model was used to investigate whether deviations from the correct molar ratio between 
COMP and collagen I might lead to changes in the supramolecular organization of the 
dermal ECM similar to those seen in fibrotic disorders. Ultrastructural analysis indeed 
revealed morphological abnormalities in the skin of overexpressing mice resembling fibrotic 
dermis. 
Collectively these results suggest that a precisely controlled amount of COMP is required to 
maintain collagen fibril spacing within the dermal ECM. Secretion of ECM components by 
COMP-deficient fibroblasts would result in structural matrix defects; in this situation 
fibroblasts would retain structural ECM components and ER stress builds up. 
Development of fibrosis is in part due to fibroblast activation by e.g. TGF and interleukin-13. 
These cytokines were shown to enhance COMP expression, thereby leading to aberrant 
molar ratios between COMP and collagen I and to disturbed collagen I fibrillogenesis. Such 
alterations were detected in fibrotically altered dermis and in the dermal ECM of COMP 
overexpressing mice. 
This work showed for the first time that COMP does not only regulate collagen fibrillogenesis 
but has a major impact on the structure of the collagen network and controls protein 
secretion of fibroblasts. Variations in the expression level of COMP result in an altered 
structure of the extracellular matrix and are responsible for a characteristic fibrotic 
arrangement of the collagen fibrils.  
 
